TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 26 08 2019
accepted: 26 11 2019
revised: 10 11 2019
pubmed: 12 12 2019
medline: 17 6 2020
entrez: 12 12 2019
Statut: ppublish

Résumé

Metastasis is the most frequent cause of death in cancer patients. Epithelial-to-mesenchymal transition (EMT) is the process in which cells lose epithelial integrity and become motile, a critical step for cancer cell invasion, drug resistance and immune evasion. The transforming growth factor-β (TGFβ) signaling pathway is a major driver of EMT. Increasing evidence demonstrates that metabolic reprogramming is a hallmark of cancer and extensive metabolic changes are observed during EMT. The aim of this review is to summarize and interconnect recent findings that illustrate how changes in glycolysis, mitochondrial, lipid and choline metabolism coincide and functionally contribute to TGFβ-induced EMT. We describe TGFβ signaling is involved in stimulating both glycolysis and mitochondrial respiration. Interestingly, the subsequent metabolic consequences for the redox state and lipid metabolism in cancer cells are found to be in favor of EMT as well. Combined we illustrate that a better understanding of the mechanistic links between TGFβ signaling, cancer metabolism and EMT holds promising strategies for cancer therapy, some of which are already actively being explored in the clinic.

Identifiants

pubmed: 31822964
doi: 10.1007/s00018-019-03398-6
pii: 10.1007/s00018-019-03398-6
pmc: PMC7256023
doi:

Substances chimiques

Transforming Growth Factor beta 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2103-2123

Subventions

Organisme : Center for Cancer Genomics
ID : CCG.NL
Organisme : Chinese Scholarship Council
ID : CSC

Références

Front Oncol. 2017 Mar 14;7:40
pubmed: 28352611
J Clin Invest. 2013 Sep;123(9):3685-92
pubmed: 23999443
FASEB J. 2010 Dec;24(12):4889-903
pubmed: 20720159
Oncotarget. 2016 Aug 9;7(32):51553-51568
pubmed: 27303921
Blood. 2007 May 1;109(9):3812-9
pubmed: 17255361
Nat Rev Mol Cell Biol. 2018 Jul;19(7):419-435
pubmed: 29643418
Dev Cell. 2019 May 6;49(3):313-316
pubmed: 31063750
Trends Mol Med. 2017 May;23(5):411-429
pubmed: 28427863
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
Nature. 2003 Oct 9;425(6958):577-84
pubmed: 14534577
Future Oncol. 2010 Apr;6(4):551-62
pubmed: 20373869
Nat Med. 2015 Feb;21(2):178-84
pubmed: 25599133
Clin Cancer Res. 2012 Jun 15;18(12):3261-9
pubmed: 22510345
Nat Cell Biol. 2009 Aug;11(8):943-50
pubmed: 19597490
Exp Mol Pathol. 2014 Oct;97(2):259-65
pubmed: 25084322
FEBS J. 2017 Oct;284(20):3437-3454
pubmed: 28834297
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195692
Oncotarget. 2016 Oct 11;7(41):66660-66678
pubmed: 27556502
Science. 2000 Feb 4;287(5454):848-51
pubmed: 10657297
Cancer Cell. 2005 Oct;8(4):311-21
pubmed: 16226706
J Clin Med. 2019 May 14;8(5):
pubmed: 31091749
Antioxid Redox Signal. 2016 Aug 20;25(6):300-25
pubmed: 27353526
Oncotarget. 2016 Aug 23;7(34):55543-55554
pubmed: 27765901
Anticancer Res. 2017 Mar;37(3):987-995
pubmed: 28314256
Clin Exp Immunol. 2019 Aug;197(2):153-160
pubmed: 30873592
Front Immunol. 2017 Apr 05;8:374
pubmed: 28424698
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Curr Opin Genet Dev. 2011 Feb;21(1):93-9
pubmed: 21251810
Cell. 2013 Aug 1;154(3):651-63
pubmed: 23911327
Br J Cancer. 2016 Mar 29;114(7):759-66
pubmed: 26986252
Expert Opin Ther Targets. 2017 Nov;21(11):1001-1016
pubmed: 28922023
Cancer Metab. 2016 Oct 17;4:19
pubmed: 27777765
Biochim Biophys Acta. 2011 Nov;1811(11):637-47
pubmed: 21704189
Nat Cell Biol. 2018 Apr;20(4):479-491
pubmed: 29593326
Cancer Discov. 2016 Jul;6(7):727-39
pubmed: 27231123
Cell. 2014 Aug 28;158(5):1094-1109
pubmed: 25171410
Int J Cancer. 2019 Jan 1;144(1):178-189
pubmed: 30226266
Oncogene. 2015 Jul 23;34(30):3908-16
pubmed: 25284588
Biochem Biophys Res Commun. 2017 Mar 11;484(3):687-693
pubmed: 28161638
Nature. 1997 Oct 9;389(6651):631-5
pubmed: 9335507
Int J Mol Med. 2016 Oct;38(4):1235-42
pubmed: 27573422
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Trends Cell Biol. 2019 Mar;29(3):212-226
pubmed: 30594349
J Biol Chem. 2004 Apr 30;279(18):18688-93
pubmed: 14976195
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Cancer Metastasis Rev. 2012 Dec;31(3-4):553-68
pubmed: 22714591
Eur J Biochem. 1982 Dec;129(1):191-5
pubmed: 6297885
Mol Biol Cell. 2001 Jan;12(1):27-36
pubmed: 11160820
Oncogene. 2002 Jun 20;21(27):4317-22
pubmed: 12082619
Cell Cycle. 2005 Jan;4(1):63-6
pubmed: 15611645
Cold Spring Harb Perspect Biol. 2016 Oct 3;8(10):
pubmed: 27449814
Oncogene. 2015 Oct 8;34(41):5229-39
pubmed: 25659582
Cell. 2017 Feb 9;168(4):657-669
pubmed: 28187287
Ann Oncol. 2010 Oct;21 Suppl 7:vii89-92
pubmed: 20943648
Cancers (Basel). 2018 Oct 22;10(10):
pubmed: 30360374
Trends Cancer. 2017 Jan;3(1):56-71
pubmed: 28718426
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Thorax. 2012 Feb;67(2):147-56
pubmed: 22106015
Nat Rev Clin Oncol. 2017 Jan;14(1):11-31
pubmed: 27141887
Neuro Oncol. 2009 Aug;11(4):368-80
pubmed: 19033423
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11553-11554
pubmed: 31138691
Cancer Res. 2003 Sep 1;63(17):5615-21
pubmed: 14500403
Cancer Metab. 2014 Dec 15;2:21
pubmed: 25671108
Prog Lipid Res. 2004 May;43(3):266-81
pubmed: 15003397
Sci Signal. 2019 Feb 26;12(570):
pubmed: 30808818
Sci Rep. 2016 Dec 16;6:38646
pubmed: 27982105
Cell Adh Migr. 2015;9(4):317-24
pubmed: 26241004
Arch Pharm Res. 2015 Mar;38(3):313-20
pubmed: 25634102
Clin Cancer Res. 2015 Jun 1;21(11):2440-4
pubmed: 25838393
J Cell Physiol. 2002 Apr;191(1):1-16
pubmed: 11920677
Oncogenesis. 2016 Jan 25;5:e189
pubmed: 26807644
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15526-31
pubmed: 25313085
Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30
pubmed: 22992590
FEBS J. 2017 Oct;284(19):3132-3144
pubmed: 28444969
Biochem Biophys Res Commun. 2002 Aug 23;296(3):580-3
pubmed: 12176020
Cancer Res. 2011 Nov 15;71(22):6921-5
pubmed: 22084445
EMBO Rep. 2018 Jan;19(1):135-155
pubmed: 29233829
EMBO J. 2004 Jan 14;23(1):33-44
pubmed: 14685263
Biochim Biophys Acta. 2007 Jan;1775(1):21-62
pubmed: 16904831
Cell Metab. 2016 Nov 8;24(5):657-671
pubmed: 27641098
Pharmacol Ther. 2015 Jun;150:33-46
pubmed: 25595324
Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50
pubmed: 18216770
Nat Rev Drug Discov. 2013 Nov;12(11):829-46
pubmed: 24113830
Development. 1990 Oct;110(2):445-60
pubmed: 2133548
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Oncotarget. 2016 Sep 27;7(39):63324-63337
pubmed: 27556509
J Clin Oncol. 2003 Sep 15;21(18):3462-8
pubmed: 12972521
Cold Spring Harb Perspect Biol. 2016 Aug 01;8(8):
pubmed: 27481709
EMBO J. 1998 Jun 1;17(11):3091-100
pubmed: 9606191
Science. 2009 Sep 18;325(5947):1555-9
pubmed: 19661383
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7461-6
pubmed: 19380734
Int J Mol Sci. 2015 Jan 02;16(1):924-49
pubmed: 25561239
Annu Rev Pharmacol Toxicol. 2013;53:401-26
pubmed: 23294312
Cancer Res. 2016 Oct 1;76(19):5743-5755
pubmed: 27302170
J Biol Chem. 2014 Sep 5;289(36):25382-92
pubmed: 25053415
Oncogene. 2018 Nov;37(48):6195-6211
pubmed: 30002444
Biochim Biophys Acta. 2011 Nov;1807(11):1432-43
pubmed: 21771581
J Cell Biol. 2007 Jul 30;178(3):437-51
pubmed: 17646396
Dev Cell. 2008 Jun;14(6):818-29
pubmed: 18539112
Redox Biol. 2015 Dec;6:565-577
pubmed: 26496488
Hum Mol Genet. 2014 May 1;23(9):2440-6
pubmed: 24334767
Cancer Cell. 2013 Jun 10;23(6):739-52
pubmed: 23707781
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Front Oncol. 2017 Dec 01;7:295
pubmed: 29250487
Br J Cancer. 2008 Oct 7;99(7):989-94
pubmed: 18766181
Cell Rep. 2014 Aug 7;8(3):754-66
pubmed: 25066121
J Biol Chem. 2012 Dec 7;287(50):42180-94
pubmed: 23038259
Cancer Res. 2004 Jan 1;64(1):31-4
pubmed: 14729604
Free Radic Biol Med. 2012 Oct 1;53(7):1489-99
pubmed: 22728268
Nature. 2016 Aug 31;537(7621):544-547
pubmed: 27580029
Curr Opin Genet Dev. 2010 Feb;20(1):51-6
pubmed: 19942427
Transl Oncol. 2016 Dec;9(6):512-520
pubmed: 27816688
Cell. 2008 Jul 25;134(2):215-30
pubmed: 18662538
Cold Spring Harb Perspect Biol. 2017 Apr 3;9(4):
pubmed: 27920038
Cancer Res. 2007 Dec 1;67(23):11284-90
pubmed: 18056454
Chem Rev. 2018 Jul 25;118(14):6893-6923
pubmed: 29939018
Nat Rev Cancer. 2011 Feb;11(2):85-95
pubmed: 21258394
J Am Soc Nephrol. 2005 Mar;16(3):667-75
pubmed: 15677311
Int J Mol Sci. 2018 Nov 20;19(11):
pubmed: 30463358
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
Biochem Biophys Res Commun. 2014 Jan 17;443(3):821-7
pubmed: 24342608
Nat Rev Cancer. 2013 Feb;13(2):97-110
pubmed: 23344542
Gastroenterology. 2018 Nov;155(5):1463-1473.e6
pubmed: 30059671
Curr Opin Cell Biol. 2018 Apr;51:1-7
pubmed: 29149681
Cancer Discov. 2012 Mar;2(3):248-59
pubmed: 22585995
Nature. 1994 Aug 4;370(6488):341-7
pubmed: 8047140
Nat Cell Biol. 2014 Jun;16(6):488-94
pubmed: 24875735
Cancer Metab. 2014 Nov 03;2(1):20
pubmed: 25379179
Cancer Cell. 2011 Jan 18;19(1):17-30
pubmed: 21251613
Genomics. 2004 Dec;84(6):1014-20
pubmed: 15533718
Kidney Int. 1999 May;55(5):1704-12
pubmed: 10231432
Trends Cell Biol. 2013 Oct;23(10):484-92
pubmed: 23756093
Cancer Res. 2007 Sep 1;67(17):8180-7
pubmed: 17804731
Nature. 2017 Jan 5;541(7635):41-45
pubmed: 27974793
FEBS J. 2012 Aug;279(15):2610-23
pubmed: 22621751
Cancers (Basel). 2018 Dec 31;11(1):
pubmed: 30602670
Cancers (Basel). 2019 May 24;11(5):
pubmed: 31137748
Nat Chem Biol. 2016 Oct;12(10):779-86
pubmed: 27479743
Free Radic Biol Med. 2014 Feb;67:285-91
pubmed: 24239742
Biochim Biophys Acta. 2014 May;1841(5):692-703
pubmed: 24355909
NMR Biomed. 2010 Jul;23(6):633-42
pubmed: 20623626
Curr Opin Cell Biol. 2014 Dec;31:56-66
pubmed: 25240174
Nat Genet. 2002 Apr;30(4):406-10
pubmed: 11865300
Nat Rev Cancer. 2018 Jan;18(1):33-50
pubmed: 29147025
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
Anticancer Res. 2013 Oct;33(10):4431-8
pubmed: 24123012
Cancer Res. 2006 May 15;66(10):5216-23
pubmed: 16707446
Cell. 2016 Feb 25;164(5):1015-30
pubmed: 26898331
Cell Tissue Res. 2002 Jan;307(1):1-14
pubmed: 11810309
Cancer Cell. 2009 Sep 8;16(3):195-207
pubmed: 19732720
Cancer Cell. 2008 Jun;13(6):472-82
pubmed: 18538731
Prog Lipid Res. 2016 Jul;63:28-40
pubmed: 27073147
Neoplasma. 2010;57(3):234-40
pubmed: 20353274
Cell Death Differ. 2017 Jan;24(1):1-2
pubmed: 27886164
Sci Rep. 2016 Jan 04;6:18669
pubmed: 26725848
EMBO Rep. 2015 Mar;16(3):321-31
pubmed: 25643708
Br J Cancer. 2014 Jan 21;110(2):330-40
pubmed: 24281000
Nat Rev Immunol. 2004 Mar;4(3):181-9
pubmed: 15039755
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4300-4305
pubmed: 28400509
Int J Biol Sci. 2014 Jan 20;10(2):171-80
pubmed: 24520215
Curr Opin Oncol. 2013 Jan;25(1):76-84
pubmed: 23197193
PLoS One. 2015 Jul 30;10(7):e0132978
pubmed: 26226105
Cancer Lett. 2015 Jan 28;356(2 Pt A):156-64
pubmed: 24732809
Mol Biol Cell. 2011 May 15;22(10):1686-98
pubmed: 21411626
Mol Cancer. 2017 Apr 11;16(1):76
pubmed: 28399876
Neuro Oncol. 2016 Jan;18(1):16-26
pubmed: 26188014
Mol Cell. 2000 Dec;6(6):1365-75
pubmed: 11163210
Mol Biol Cell. 2007 Apr;18(4):1437-46
pubmed: 17301289
Cell. 2012 Apr 27;149(3):656-70
pubmed: 22541435
Oncogene. 2009 Jul 2;28(26):2425-35
pubmed: 19448670
Oncotarget. 2016 Jun 1;8(34):56081-56094
pubmed: 28915575
Sci Signal. 2019 Feb 26;12(570):
pubmed: 30808819
Oncotarget. 2016 Nov 8;7(45):73414-73431
pubmed: 27705917
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Sci Rep. 2016 Nov 08;6:36289
pubmed: 27824159
Nature. 2012 Feb 15;483(7390):474-8
pubmed: 22343901
Front Nutr. 2015 Jan 05;1:27
pubmed: 25988127
Mol Med Rep. 2019 Feb;19(2):1159-1167
pubmed: 30535436
Cell. 2000 Oct 13;103(2):295-309
pubmed: 11057902
Nat Rev Mol Cell Biol. 2017 Feb;18(2):90-101
pubmed: 27924077
Sci Rep. 2015 Oct 01;5:14752
pubmed: 26424075
Cancer Metab. 2014 Jul 29;2:11
pubmed: 25097756
Sci Rep. 2015 Dec 03;5:17454
pubmed: 26632252
Mol Cell Biol. 2012 May;32(10):1893-907
pubmed: 22431524
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13235-40
pubmed: 25157127

Auteurs

Wan Hua (W)

Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Einthovenweg 20, 2300 RC, Leiden, The Netherlands.
National and Local Joint Engineering Laboratory for Energy Plant Bio-Oil Production and Application, Key Laboratory of Bio-resources and Eco-environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, People's Republic of China.

Peter Ten Dijke (P)

Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Einthovenweg 20, 2300 RC, Leiden, The Netherlands. p.ten_dijke@lumc.nl.

Sarantos Kostidis (S)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.

Martin Giera (M)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.

Marten Hornsveld (M)

Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Einthovenweg 20, 2300 RC, Leiden, The Netherlands. m.hornsveld@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH